MANNS PHARMACY LIMITED

Company Registration Number:
03881759 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

MANNS PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Balance sheet
Notes

MANNS PHARMACY LIMITED

Balance sheet

As at 31 December 2024


Notes
2024
2023


£
£
Fixed assets
Intangible assets: 3 540,595 1,265,595
Tangible assets: 4 35,033 52,463
Total fixed assets: 575,628 1,318,058
Current assets
Stocks: 39,539 87,338
Debtors:   153,564 240,941
Cash at bank and in hand: 658,010 57,310
Total current assets: 851,113 385,589
Creditors: amounts falling due within one year:   (85,520) (188,138)
Net current assets (liabilities): 765,593 197,451
Total assets less current liabilities: 1,341,221 1,515,509
Total net assets (liabilities): 1,341,221 1,515,509
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 1,341,121 1,515,409
Shareholders funds: 1,341,221 1,515,509

The notes form part of these financial statements

MANNS PHARMACY LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 31 October 2025
and signed on behalf of the board by:

Name: Mr G S Mann
Status: Director

The notes form part of these financial statements

MANNS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MANNS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

2. Employees

2024 2023
Average number of employees during the period 4 9

MANNS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Intangible Assets

Total
Cost £
At 01 January 2024 1,265,595
Disposals (725,000)
At 31 December 2024 540,595
Net book value
At 31 December 2024 540,595
At 31 December 2023 1,265,595

MANNS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Tangible Assets

Total
Cost £
At 01 January 2024 138,649
At 31 December 2024 138,649
Depreciation
At 01 January 2024 86,186
Charge for year 17,430
At 31 December 2024 103,616
Net book value
At 31 December 2024 35,033
At 31 December 2023 52,463